User profiles for Juan Antonio Carrillo

Juan Antonio Carrillo Norte

Profesor de Farmacología Clínica
Verified email at unex.es
Cited by 3976

Role of the smoking-induced cytochrome P450 (CYP) 1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

JA Carrillo, AG Herráiz, SI Ramos… - Journal of clinical …, 2003 - journals.lww.com
This study investigated whether the smokinginducible cytochrome P450 (CYP) 1A2 and the
polymorphic CYP2D6 play significant roles in the metabolism of olanzapine and its clinical …

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in …

E Aklillu, JA Carrillo, E Makonnen, K Hellman… - Molecular …, 2003 - ASPET
CYP1A2 polymorphism has been well studied in white persons and Asians but not in Africans.
We performed CYP1A2 genotype and phenotype analysis using caffeine in Ethiopians …

Clinically significant pharmacokinetic interactions between dietary caffeine and medications

JA Carrillo, J Benitez - Clinical pharmacokinetics, 2000 - Springer
Caffeine from dietary sources (mainly coffee, tea and soft drinks) is the most frequently and
widely consumed CNS stimulant in the world today. Because of its enormous popularity, the …

Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine

JA Carrillo, M Christensen, SI Ramos… - Therapeutic drug …, 2000 - journals.lww.com
Twenty-five healthy volunteers were given 100 mg caffeine orally and several estimates of
cytochrome P450 1A2 (CYP1A2) activity were evaluated. The validation was performed by …

Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy

G Gervasini, J Benítez, JA Carrillo - European journal of clinical …, 2010 - Springer
Genetic factors contribute to the phenotype of drug response, but the translation of
pharmacogenetic outcomes into drug discovery, drug development or clinical practice has proved to …

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2‐receptor antagonists

…, JAG Agúndez, E Herrero, JA Carrillo… - Clinical …, 1999 - Wiley Online Library
The isozymes CYP1A2, CYP2D6, and CYP3A4/5 are involved in the majority of all cytochrome
P450– mediated drug biotransformations. In this study we investigated the inhibition …

Adenosine triphosphate‐binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer

…, JA Carrillo, M Garcia, C San Jose, A Cabanillas… - Cancer, 2006 - Wiley Online Library
BACKGROUND. P‐glycoprotein (P‐gp) is a transmembrane transporter that is encoded by
the adenosine triphosphate‐binding cassette B1 (ABCB1) (multidrug resistance 1) gene, …

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

JA Carrillo, ML Dahl, JO Svensson… - Clinical …, 1996 - Wiley Online Library
Background Fluvoxamine is a selective serotonin reuptake inhibitor used widely in the
treatment of depression and other psychiatric diseases, but little is known about the specific …

Low daily 10‐mg and 20‐mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)

…, K Mihara, N Yasui‐Furokori, JA Carrillo… - Clinical …, 2002 - Wiley Online Library
Objectives Fluvoxamine is metabolized by the polymorphic cytochrome P450 (CYP) 2D6
and the smoking‐inducible CYP1A2. Therapeutic doses of fluvoxamine inhibit both CYP1A2 …

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

JA CARRILLO, J BENITEZ - British journal of clinical …, 1996 - Wiley Online Library
We have investigated several factors that might be related to the occurrence of toxic effects
during the performance of a urinary test with caffeine (300 mg po), in 120 healthy volunteers. …